Studies have demonstrated that miR-223 transcriptional suppression of NLRP3 could promote apoptosis in breast cancer, hepatocellular cancer, cervical cancer, and glioblastoma cells [64,65,66,67]. This evidence concerns the gene NLRP3 and breast cancer.